Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Alexander C. Okwonna, PharmD

Articles by Alexander C. Okwonna, PharmD

Correspondence regarding, "Cost Effectiveness of Thromboprophylaxis With a Low-Molecular-Weight Heparin Versus Unfractionated Heparin in Acutely Ill Medical Inpatients"

ByAlexander C. Okwonna, PharmD,Sujit S. Sansgiry, PhD

March 1st 2005

Latest Updated Articles

$Correspondence regarding, "Cost Effectiveness of Thromboprophylaxis With a Low-Molecular-Weight Heparin Versus Unfractionated Heparin in Acutely Ill Medical Inpatients"$
Correspondence regarding, "Cost Effectiveness of Thromboprophylaxis With a Low-Molecular-Weight Heparin Versus Unfractionated Heparin in Acutely Ill Medical Inpatients"
Published: March 1st 2005 | Updated:

Trending on AJMC

Pirtobrutinib Shows Clinically Meaningful PFS Improvement in Frontline CLL

AHA Launches New Initiative to Help Patients With Heart Failure

AML Survival After 3 Years in Remission Comparable With General Population

Second Known Case of Concurrent ET, WM Raises Questions About Their Coexistence

CSU More Burdensome in Female Patients, Especially in Midlife

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

© 2025 MJH Life Sciences^®

All rights reserved.